MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 19, 2007; DOI: 10.1124/mol.107.035642


0026-895X/07/7201-191-196$20.00
Mol Pharmacol 72:191-196, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.035642v1
72/1/191    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kollau, A.
Right arrow Articles by Mayer, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kollau, A.
Right arrow Articles by Mayer, B.

Bioactivation of Nitroglycerin by Ascorbate

Alexander Kollau, Matteo Beretta, Antonius C. F. Gorren, Michael Russwurm, Doris Koesling, Kurt Schmidt, and Bernd Mayer

Department of Pharmacology and Toxicology, Karl-Franzens-Universität Graz, Graz, Austria (A.K., M.B., A.C.F.G., K.S., B.M.); and Department of Pharmacology and Toxicology, Ruhr-Universität Bochum, Bochum, Germany (M.R., D.K.)

Bioactivation of nitroglycerin (GTN) into an activator of soluble guanylate cyclase (sGC) is essential for the vasorelaxant effect of the drug. Besides several enzymes that catalyze GTN bioactivation, the reaction with cysteine is the sole nonenzymatic mechanism known so far. Here we show that a reaction with ascorbate results in GTN bioactivation. In the absence of ascorbate, GTN did not affect the activity of purified sGC. However, the enzyme was activated to ~20% of maximal NO-stimulated activity by GTN in the presence of 10 mM ascorbate with an EC50 value of 27.3 ± 4.9 µM GTN. The EC50 value of ascorbate was 0.11 ± 0.011 mM. Activation of sGC was sensitive to oxyhemoglobin, superoxide, and a heme-site enzyme inhibitor. GTN had no effect when ascorbate was replaced by 1000 U of superoxide dismutase per milliliter. Ascorbate is known to reduce inorganic nitrite to NO. In the presence of 10 mM ascorbate, ~30 µM nitrite caused the same increase in sGC activity as 0.3 mM GTN. Determination of ascorbate-driven 1,2- and 1,3-glycerol dinitrate formation indicated that a 140 nM concentration of products was generated from 0.3 mM GTN within 10 min, excluding nitrite as a relevant intermediate. Our results suggest that a reaction between GTN and ascorbate or an ascorbate-derived species yields an activator of sGC with NO-like chemical properties. This reaction may contribute to GTN bioactivation in blood vessels under conditions of GTN tolerance and ascorbate supplementation.


Received March 1, 2007; accepted April 19, 2007

Address correspondence to: Dr. Bernd Mayer, Department of Pharmacology and Toxicology, Karl-Franzens-Universität Graz, Universitätsplatz 2, A-8010 Graz, Austria. E-mail: mayer{at}uni-graz.at




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
G. Wolkart, M. V. Wenzl, M. Beretta, H. Stessel, K. Schmidt, and B. Mayer
Vascular tolerance to nitroglycerin in ascorbate deficiency
Cardiovasc Res, July 15, 2008; 79(2): 304 - 312.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Beretta, K. Gruber, A. Kollau, M. Russwurm, D. Koesling, W. Goessler, W. M. Keung, K. Schmidt, and B. Mayer
Bioactivation of Nitroglycerin by Purified Mitochondrial and Cytosolic Aldehyde Dehydrogenases
J. Biol. Chem., June 27, 2008; 283(26): 17873 - 17880.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. P. Cokic, S. A. Andric, S. S. Stojilkovic, C. T. Noguchi, and A. N. Schechter
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
Blood, February 1, 2008; 111(3): 1117 - 1123.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics